Aortic stenosis induces pressure overload and myocardial remodelling with concentric hypertrophy and alterations in extracellular matrix (ECM). Aortic valve replacement leads to reverse remodelling, a process of which knowledge is scarce. The aims of the present study were to examine alterations in myocardial gene expression and subsequently identify molecular alterations important for the early phase of reverse remodelling.
Introduction
Aortic stenosis (AS) causes pressure overload and induces myocardial remodelling with development of concentric hypertrophy and alterations in the extracellular matrix (ECM). Altered ECM with increased collagen content leads to reduced myocardial compliance and diastolic dysfunction. 1 Aortic valve replacement (AVR)
is the treatment for AS and may lead to normalization of both myocardial hypertrophy and the alterations in ECM, 2 a process known as reverse remodelling. However, reduced function may persist post-operatively after AVR, 3 and little is known about the causes for these clinical observations. In this regard, the alterations of ECM, or lack of such, in the early phase after a reduction in pressure overload of the left ventricle (LV) may be of particular interest. Structural proteins in the ECM (e.g. collagens) might be regulated by a number of mediators including members of the transforming growth factor-b (TGF-b) superfamily, 4 and these may play a role during reverse remodelling. It has been shown that potential mediators of reverse remodelling are regulated both in the myocardium and in the circulation in association with alterations in cardiac stress, 5, 6 such as after AVR. 7, 8 However, mediators of reverse remodelling and the alterations occurring in the ECM during the early phase of reverse remodelling are not well known. There are several possible changes that may occur in the ECM during reverse remodelling. Both the quantity of structural proteins and the composition might be altered. In particular, alterations in collagen subtypes may be important for cardiac function, since they have been reported to possess different physiological characteristics. 1 The aims of the present study were to examine alterations in myocardial gene expression and subsequently to identify molecular alterations important for the early phase of reverse remodelling. To mimic changes taking place in AS and following AVR in humans, we established a mouse model of reversible banding of the ascending aorta and performed a careful characterization of the model by echocardiography 3, 7, and 14 days after debanding (DB). Following microarray screening of the myocardial tissue, we used the Bioconductor software package topGO (topology-based Gene Ontology scoring) 9 for functional interpretation of the results. We found that 'extracellular matrix structural constituents' was the most strongly regulated gene group during the early phase of reverse remodelling, and this finding led us to identify a not previously described collagen isoform shift.
Methods

Animal preparation
Anaesthesia was induced in 7-week-old male C57BL/6 mice with .5% isoflurane gas and ,95% O 2 in a gas chamber, followed by orotracheal intubation and ventilation with 2% isoflurane and 98% O 2 , with a tidal volume of 350 mL and a respiratory frequency of 160 min 21 on a MiniVent ventilator (Harvard Apparatus, Holliston, MA, USA). Via a leftsided thoracotomy in the second intercostal space, an 8-0 silk ligature was tied around the ascending aorta and a 26 G blunted needle, which was subsequently removed. In sham-operated animals [sham aortic banding (sAB)], the ligature was tied loosely around the aorta. When the development of hypertrophy had reached a stable plateau phase 10 4 weeks after aortic banding (AB), a debanding operation (DB) was performed, carefully removing the ligature and constricting fibrosis via an upper hemisternotomy. To avoid possible confounding effects of the recent surgical trauma, sAB animals were also subjected to a second operation (sDB), with removal of the loose ligature. Before sacrifice, animals were anaesthetized with isoflurane gas and intubated. Blood was then drawn from the inferior vena cava and the heart and lungs were rapidly excised. The LV was separated from the right ventricle and the atria, weighed and snap-frozen in liquid nitrogen. Left ventricular weight (LVW) and lung weight (LW) were normalized to tibia length. Animals were handled according to the National Regulation on Animal Experimentation in accordance with the Norwegian Animal Welfare Act. The protocol was approved by the Norwegian National Animal Research Committee.
Echocardiography
Echocardiography was carried out before DB and before sacrifice. Recordings were done using the VIVID 7 system (GE Vingmed Ultrasound, Horten, Norway) and an i13L 13 MHz linear array transducer designed for the examination of small rodents, which allows for high resolution. Examinations were performed under standardized conditions with the animals in the supine position, spontaneously breathing 1.5% isoflurane and 98.5% O 2 on a mask. Recordings were interpreted off-line using EchoPac PC 3.0x software (GE ) were recorded from the basal part of the posterior wall in the long-axis view. Pulsed wave Doppler was used for measuring flow velocities across the constriction, as well as in the ascending aorta proximal to the constriction, in the mitral annulus, and the pulmonary artery. Cardiac output was calculated using the formula (3.14 × (1/2 × diameter ascending aorta ) 2 × VTI ascending aorta × HR).
Experimental protocol
Aortic banding and sAB animals were sacrificed 4 weeks after the primary operation and DB and sDB animals either 3, 7, or 14 days (DB3, DB7, DB14, sDB3, sDB7, and sDB14) after DB. In our experience, AB animals with V max , 3 m/s (corresponding to a pressure gradient of 36 mmHg using the modified Bernoulli equation) across the aortic constriction often developed inadequate LV hypertrophy, and these animals were therefore excluded from further studies. As an important purpose of this model was to study regression of hypertrophy, we defined LVM . 111.5 mg (sham average weight + 30%) as an additional inclusion criterion for banded animals; however, all animals with V max ≥ 3 m/s fulfilled this criterion. Echocardiographic examinations and organ weights from banded and sham-banded animals were examined to identify the best parameter for identifying mice with pulmonary congestion. An LAD cut-off value of 2.2 mm was used to identify animals with pulmonary congestion. This corresponded to a 50% increase in LW above mean LW in sham-operated animals ( Figure 1 ). To avoid possible confounding effects of heart failure, animals with LAD . 2.2 mm were excluded from this study.
One animal with signs of residual stenosis after DB was also excluded. 
Microarray
Microarrays were carried out using Affymetrix GeneChip w Mouse Genome 430 2.0 Array (Affymetrix, Inc., Santa Clara, CA, USA), containing 45.101 probe sets. Three animals from each of the AB, sAB, DB3, and sDB3 groups were used for the microarray analyses. Microarray pre-processing involved background adjustment using gcrma (Guanine Cytosine Robust Multi-Array Analysis) which normalizes data and adjusts for background intensities taking optical noise and non-specific binding into account 11 and control of false discovery rate (FDR) according to Benjamini and Hochberg. 12 The microarray data were analysed using a standard ANOVA model for each gene. A 30% alteration of expression, corresponding to ANOVA coefficients + 0.3875, was used as a cut-off value for considering genes to be regulated. To improve the functional interpretation of the microarray results, we used the Bioconductor software package topGO, 9 as biological function can be difficult to understand from regulation of single genes. topGO scores functional GO groups using a refined bioinformatics algorithm taking local dependencies between GO terms into account. In the topGO analyses, FDR , 0.05 was used as an inclusion criterion and the GO groups were ranked using the weight algorithm. 
Real-time polymerase chain reaction
Real-time polymerase chain reaction (RT-PCR) was carried out in a 7900 HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). All samples were run in triplicate on 96-well optical PCR plates (Applied Biosystems) in a final reaction volume of 25 mL. The PCR parameters were 1 cycle at 508C for 2 min, 1 cycle at 958C for 10 min, and 40 cycles at 958C for 15 s and 608C for 1 min. We also used the 96-well RT 2 Profiler TM PCR Arrays (SuperArray Bioscience Corporation, Frederick, MD, USA) to perform a focused array analysing myocardial expression of genes related to the TGF-b/BMP signaling pathway. This array analyses a pre-defined set of 84 relevant, pathway focused genes, as well as five housekeeping genes and three quality controls. We analysed LV mRNA expression of a-skeletal actin (a-SKA), myosin heavy chain-b (MHC-b), and brain natriuretic peptide (BNP) as molecular biological markers of increased cardiac load. We further analysed LV mRNA expression of matrix metalloproteinases (MMP)-2 and -9, tissue inhibitor of metalloproteinases (TIMP)-1 and -2, angiotensinogen, and angiotensin-converting enzyme (ACE) as these might contribute to the observed ECM changes following DB.
Analysis of myocardial collagen content
Quantitative analysis of tissue content of hydroxyproline was performed by HPLC using the AccQ-Fluor reagent kit (Waters Corporation Milford, MA, USA) essentially as described previously. 13 The relation of myocardial hydroxyproline content to myocardial collagen has previously been reported. 14 Briefly, cardiac tissue samples (5 mg dry weight) were hydrolysed in 6 M HCl for 16 h at 1108C and subsequently dried under vacuum and redissolved in the AccQ-Fluor borate buffer. Derivatization was initiated by addition of the AccQ-Fluor reagent at 558C and terminated after 10 min. The samples were finally subjected to HPLC using a 20 × 3.9 mm Sentry Guard column (Nova-Pak C18 bonded silica) connected to a 150 × 3.9 mm AccQ-Tag reversed-phase column (both from Waters) according to the manufacturer's instructions. Derivatized hydroxyproline was detected by fluorescence following excitation at 250 nm and recording of emission at 395 nm. Elution of hydroxyproline from myocardial tissue samples was verified and quantified by co-elution with known amounts of derivatized hydroxyproline standards (Fluka, Buchs SG, Switzerland).
Tissue sampling for western blot
Homogenates of the LV myocardium were prepared in extraction buffer containing 0.15 M NaCl, 20 mM CaCl 2 , 10 mM cacodylic acid, pH 5.0 (Sigma Aldrich, St Louis, MO, USA), 1.5 mM NaN 3 , 1 mM ZnCl 2 , and 0.01% (v/v) Triton X-100 for 12 h at 48C. After centrifugation at 1200 g for 5 min, supernatants were collected and protein concentrations were determined using Protein Assay kit from Pierce. 15 
Immunoblotting
The extracted and denatured cardiac tissue samples were separated through a 10% SDS -polyacrylamide gel and transferred to PVDF membranes (GE Healthcare Life Sciences, Uppsala, Sweden) by electrophoretic blotting. Membranes were blocked at 48C in PBSTween (0.1%) containing 5% (w/v) skimmed milk. After washing with PBS -Tween (0.1%), membranes were probed with primary antibodies for collagen types I (Southern Biotech, Birmingham, AL, USA), III (Rockland, Gilbertsville, PA, USA), and VIII (Lifespan Biosciences, Seattle, WA, USA). Peroxidase-labelled rabbit antigoat was diluted 1:3000 and used as a secondary antibody for collagen type I, and donkey antirabbit (1:3000) was used for collagen types III and VIII. The proteins were visualized by enhanced chemiluminescence according to the manufacturer's guidelines (GE Healthcare Life Sciences).
Relative intensities of protein bands were then quantified using 'Image-Quant-TL Software'. Membranes were stained with Coomassie Blue as a protein loading control.
Enzyme-linked immunosorbent assay
Aldosterone levels were determined in LV tissue homogenates and plasma using a commercially available aldosterone ELISA kit (Alpha Diagnostic International, San Antonio, TX, USA) according to the manufacturer's protocol. Left ventricular tissue was homogenized as described previously. 16 
Statistical analyses
Data are presented as mean + SEM. Differences between two groups, including comparison to sham at each time point, were analysed using two-sided Welch t-test or Mann-Whitney U-test where appropriate. Data from repeated echocardiography in debanded animals were analysed using two-sided paired t-test or Wilcoxon's signed rank test. Echocardiographic measurements from sAB, AB, and DB animals prior to DB were compared using one-way ANOVA analysis or the Kruskal -Wallis one-way analysis of variance on ranks where appropriate, using the Holm -Sidak or Dunn's method to correct for multiple testing. To analyse the effect of DB while correcting for the surgical trauma, we employed an ANOVA model including data from AB, sAB, DB3, and sDB3 animals, as well as DB7, sDB7, DB14, and sDB14, where available. The relation between continuous variables was examined by linear regression. Data not normally distributed were transformed by natural logarithm. We used P ≤ 0.05 as the level of statistical significance. SigmaPlot 9.01 (Systat Software Inc., San Jose, CA, USA) and The R Project for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, www.r-project.org) with Bioconductor packages 17 were used for the analyses.
Results
Induction of reversible left ventricular hypertrophy
Aortic banding significantly induced LV hypertrophy after 4 weeks as measured by LVW (AB 7.00 + 0.14 vs. sAB 4.85 + 0.09 mg/mm, Figure 2A ). After DB, there was a significant regression of hypertrophy to 5. Collagen isoform shift during early phase of LV remodelling
Altered expression of markers of increased cardiac load
Real-time PCR demonstrated increased LV mRNA expression of a-SKA, MHC-b, and BNP in AB animals compared with sAB ( Figure 2B-D) . a-Skeletal actin and BNP were normalized 3 days after DB. Myosin heavy chain-b expression was reduced towards sham level at 7 days after DB. a-Skeletal actin and MHC-b were not affected by surgical trauma, as there was no difference between the sham groups. However, BNP expression was lower in sDB3 compared with sAB (expression ratio 0.61, P ¼ 0.03).
Functional analysis of altered gene expression following debanding
Three days after DB, 3043 genes were up-regulated, out of which FDR was ,0.05 for 108. Expression was reduced for 2318 genes out of which FDR was ,0.05 for 166. The 'extracellular matrix structural constituent' group (GO:0005201) was the most strongly regulated following DB ( Table 2 ). The genes in this group, dominated by the collagen genes, were all up-regulated following AB, whereas the effect of DB was the reduction of expression towards sham levels ( Figure 3) . The strongest alteration in gene expression was seen for collagen type I, alpha 1 (ratios of 2.72 and 0.85 for AB:sAB and DB3:sDB3, respectively), collagen type XV, alpha 1 (3.51 and 0.89, respectively), and collagen, type VIII, alpha 1 (4.14 and 1.32, respectively). The 'actin binding' group (GO:0003779) and some enzyme-related groups were also regulated, as well as the 'transforming growth factor-b receptor binding' group (GO:0005160) ( Table 2) . Transforming growth factor-b2 was the only significantly altered gene annotated to this small GO group. On the basis of earlier findings, 8 we have explored this group of growth factors/cytokines further using a TGF-b family RT-PCR array as well as by RT-PCR (see below). GO groups, the number of gene probes annotated to each GO group and out of which the number significantly regulated as well as the P-value (n ¼ 12 mice) are given.
Myocardial collagen expression
Real-time PCR demonstrated increased mRNA expression of collagen types I, III, and XV after AB with significant down-regulation with respect to sham at 3 days after DB (ratios of 2.37 and 0.74 for AB:sAB and DB3:sDB3, respectively, for collagen type I, 2.14 and 0.53 for collagen type III, and 2.46 and 0.73 for collagen type XV, respectively). The reversible increase in LV expression of collagen type VIII (3.07 and 1.14) was also verified by RT-PCR. Expression of these four collagens was unaffected by surgery as there was no difference between the sham groups.
Myocardial collagen content
Assessment of myocardial collagen by HPLC of hydroxyproline demonstrated a 2.3-fold increase in myocardial collagen after 4 weeks of AB. The ratio vs. sham remained increased following DB; 1.6 at 3 days and 1.7 at 7 days ( Figure 4A ). Quantitative subtype measurements of myocardial collagen by western blot revealed an isoform shift as collagen type III was the only significantly increased subtype after AB. After DB, there was a 1.5-fold transient increase in myocardial collagen type I at 3 days followed by an increase in both collagen types III and VIII at 7 days ( Figure 4B -D) .
Transforming growth factor-b family, matrix metalloproteinase, tissue inhibitor of metalloproteinase, and angiotensin
Real-time-PCR of the TGF-b family revealed that mRNA expression of activin A, TGF-b2, and growth differentiation factor-15 (GDF-15) was increased after AB, with reduction after DB ( Figure 5A -C ). Expression of activin A and TGF-b2 was reduced to sham levels at 3 or 7 days after DB. Growth differentiation factor-15 expression, although significantly reduced compared with AB, remained increased compared with sham at 7 days after DB. Left ventricular mRNA expression of MMP-2, TIMP-1 and -2, and ACE was increased following AB, whereas the expression of angiotensinogen was reduced. Matrix metalloproteinase-9 was not significantly altered. Following DB, expression of these genes was not different from sham ( Table 3) .
Aldosterone
Enzyme-linked immunosorbent assay analyses demonstrated a significant increase in LV aldosterone levels at 7 days after DB compared with sham ( Table 3) . Aldosterone levels were not altered following 4 weeks of AB or at 3 days after DB. We did not reveal any difference in plasma aldosterone at any time point.
Discussion
We have studied the early phase of reverse remodelling in a mouse model of reversible pressure overload of the LV by AB and subsequent DB of the ascending aorta. Our data indicate that regression of LV remodelling starts already during the first 3 days following DB. A functional analysis of microarray data revealed alterations of collagen gene expression as the most evident transcriptional change 3 days after correction of LV pressure overload. Interestingly, 3 days after DB, collagen I protein was transiently increased, whereas collagen III and VIII proteins increased later at 7 days. This isoform shift following relief of pressure overload might have consequences for the biomechanical properties of the heart. To search for genes that may be importantly involved in reverse remodelling, we examined myocardial gene expression by microarray screening and used bioinformatics tools to identify the top altered functional gene groups, which probably gives more valuable sham aortic banding; AB, aortic banding; sDB3 sham-operated animals 3 days after debanding; DB3, 3 days after debanding; sDB7 sham-operated animals 7 days after debanding; DB7, 7 days after debanding.
biological information than simply ranking single genes. 9 'Extracellular matrix structural constituent' was the most altered group of genes following DB and this was supported by verification of the expression of four subtypes of collagen by RT-PCR. Both LV collagen gene expression and protein content were increased in mice with AB. During AB, only collagen type III content was increased after 4 weeks of pressure overload. Pressure overload has previously been reported to increase the levels of both collagen types I and III.
1 Increased myocardial content of collagen type I has been associated with maladaptive remodelling and reduced cardiac function from pressure overload, temporally preceded by adaptive remodelling and increased collagen type III. 1 Animals with signs of congestive heart failure were excluded from our study; hence, the lack of increase in type I collagen following AB might be due to this fact. As myocardial collagen remained increased while regression of hypertrophy took place, our data support the concept that reverse remodelling after relief of pressure overload is characterized by initial regression of hypertrophy followed by a late regression of fibrosis, as has been described after AVR for AS in humans. 2 During the early phase of reverse remodelling, we report for the first time a collagen subtype shift after correction of increased afterload. Following DB, the content of collagen type I was transiently increased by 50% at 3 days followed by a 70% increase in type VIII and a 30% increase in type III collagen at 7 days. In accordance with our findings, augmented synthesis of type I collagen, in particular, has been reported after complete unloading of the heart by LV assist device. 18 Increased collagen synthesis has also been reported during the initial phase of reverse remodelling after cardiac resynchronization therapy. 19 The collagen subtype shift following DB supports the notion that important changes in the ECM also takes place during the early phase of reverse remodelling.
The observed isoform shift might have biomechanical effects and alter myocardial function. Collagen type I is dominant in the Achilles tendon and is the load-bearing protein in the arteries. 20, 21 At 3 days after DB, myocardial function (FS) was slightly reduced, which might be due the increased levels of stiff collagen type I. At 7 days, myocardial function was again improved, a finding which corresponds to the decrease in collagen I and the increase in extensile 21 collagens III and VIII. Although collagen types I and III are fibrillar collagens, type VIII is a non-fibrillar collagen. It is unclear whether altered levels of collagen VIII affect the biomechanical properties of tissue directly. However, reports of collagen type VIII playing a role in tissue repair are increasing. 22 -24 Although normally not expressed in the adult heart, collagen type VIII is involved in the embryological development of the heart 25 and there are indications that collagen VIII is important for tissue remodelling. 26 Further studies are, however, needed to clarify the exact role of the collagen isoform shift in reverse remodelling. The TGF-b family has been reported to be important regulators of myocardial remodelling and ECM. 27 Thus, we analysed myocardial mRNA expression of TGF-b family members. We were, however, in this mouse model not able to verify increased activin A and GDF-15, as previously described in patients undergoing AVR for AS. 8 Species differences might be an explanation for this, or the fact that an increase in plasma concentrations does not necessarily reflect an increase in the heart. Interestingly, although reduced following DB, expression of GDF-15 remained increased with respect to sham at 3 and 7 days after DB in our model. Growth differentiation factor-15 is not expressed in the healthy adult myocardium, but is secreted after ischaemia/reperfusion. 28 Growth differentiation factor-15 was also the most up-regulated gene in biomechanically stretched cardiomyocytes. 29 Given the antihypertrophic properties of this mediator, 30 it might play a role during the early reverse remo- reported increased in serum associated with increased cross-linked carboxy-terminal telopeptide of type I and amino-terminal propeptide of type I procollagen, 31 the two latter being products of collagen I metabolism. Therefore, the increased GDF-15 after DB might be linked to the transient increase in collagen type I 3 days after DB. Left ventricular mRNA expression of MMP-2 and -9, TIMP-1 and -2, angiotensinogen, and ACE was not different from sham after DB. Thus, these factors most likely are not responsible for the rapid collagen isoform shift observed within 1 week following DB. A role for aldosterone in cardiac fibrosis has been suggested 32, 33 and increased cardiac aldosterone levels have been reported following experimental myocardial infarction. 33, 34 In our study, cardiac aldosterone levels were only increased compared with sham at 7 days after DB, concomitantly with the increase in LV collagen type VIII. Although this study was not designed to show a causal relationship between the two, it might be speculated that aldosterone is playing a role in the regulation of collagen VIII following DB. The turnover rate for the different collagen isoforms remains to be elucidated. If turnover of collagen type I is slow, a rapid regression in cardiomyocyte size following DB could indirectly contribute to the apparent increase in collagen type I at 3 days after DB if the area of regressed hypertrophy is occupied by a larger relative amount of collagen.
Our animal model developed a stable hypertrophy 4 weeks after AB. 10 In this study, AB led to a 60% increase in LVM and a six-to eight-fold increase in myocardial expression of a-SKA and MHC-b, clearly demonstrating myocardial remodelling from pressure overload. Fourteen days after DB, LVM was no longer different from sham. Two groups have previously elegantly reported mouse models of reversible constriction located between the carotid arteries on the transverse aorta (TAC). 35 -37 The banding of the ascending aorta in our model is located more proximally than in TAC and gave a higher pressure gradient (69 + 5 vs. 28 + 4 mmHg 35 ) and more LVM increase (60 vs. 35% 37 ). Banding of the ascending aorta may resemble human AS even more than TAC since the latter model also has increased pressure in the right side of the brain which is not the case in AS and banding of the ascending aorta. The few studies that exist of reverse remodelling have been carried out during the intermediate or late phase, after normalization of LVM, 37,38 while we in this study have examined reverse remodelling during the early phase, before LVM returns to sham level.
In conclusion, a functional analysis revealed that alterations in collagen gene expression were the most evident transcriptional changes after correction of LV pressure overload. Although total collagen protein remained increased following DB, there was a change in isoform constitution as collagen type I increased transiently at 3 days followed by a later increase in types III and VIII at 7 days after DB. This collagen subtype shift during the early phase of reverse remodelling might be important for the biomechanical properties of the heart and the recovery of cardiac function.
